Expression of αb-crystallin overrides the anti-apoptotic activity of XIAP

Neuro-Oncology

Volumn 14, Issue 11, 2012, Pages 1332-1345

  Lee, Jee Suk ^a   Kim, Hye Young ^a   Jeong, Na Young ^a   Lee, Sang Yeob ^a   Yoon, Young Geol ^a,e   Choi, Yung Hyun ^b   Yan, Chunlan ^c   Chu, In Sun ^d   Koh, Hyungjong ^a   Park, Hwan Tae ^a   Yoo, Young Hyun ^a  

^a Dong A University   (South Korea)

^b Dong Eui University   (South Korea)

^c ZHEJIANG UNIVERSITY   (China)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^e Jungwon University   (South Korea)

Author keywords

B crystallin; apoptosis; glioma; SAHA; XIAP

Indexed keywords

ALPHA CRYSTALLIN; BETA CRYSTALLIN; CASPASE 3; VORINOSTAT; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CYTOTOXICITY; GLIOMA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ALPHA-CRYSTALLIN B CHAIN; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; FLOW CYTOMETRY; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MICROSCOPY, CONFOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84868010015     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos247     Document Type: Article

References (54)

1. Wistow G, Piatigorsky J. Lens crystallins: the evolution and expression of proteins for a highly specialized tissue. Annu Rev Biochem. 1988;57:479-504.
2. Iwaki T, Kume-Iwaki A, Goldman JE. Cellular distribution of aB-crystallin in nonlenticular tissues. J Histo chem Cytochem. 1990;38:31-39.
3. Kato K, Shinohara H, Kurobe N, et al. Immunoreactive alpha A crystalline in rat non-lenticular tissued detected with a sensitive immunoassay method. Biochim Biophys Acta. 1991;1080:173-180.
4. Horwitz J. Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci USA. 1992;89:10449-10453.
5. Dimberg A, Rylova S, Dieterich LC, et al. Alpha-B-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis. Blood. 2008;111:2015-2023.
6. Budihardjo I, Oliver H, Lutter M, et al. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol. 1999;15:269-290.
7. Bratton SB, Walker G, Srinivasula SM, et al. Recruitment, activation and retention of caspases-9 and-3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J. 2001;20:998-1009.
8. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998;281:1312-1316.
9. Green DR. Apoptotic pathways: the roads to ruin. Cell. 1998;94:695-698.
10. Zou H, Yang R, Hao J, et al. Regulation of the Apaf-1/caspase-9 apoptosome by caspase-3 and XIAP. J Biol Chem. 2003;278:8091-8098.
11. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 2004;5:897-907.
12. Lee AY, Lee Y, Park YK, et al. HS 1-associated protein X-1 is cleaved by caspase-3 during apoptosis. Mol Cells. 2008;25:86-90.
13. Mehlen P, Mehlen A, Guillet D, et al. Tumor necrosis factor-alpha induces changes in the phosphorylation, cellular localization, and oligomerization of human hsp27, a stress protein that confers cellular resistance to this cytokine. J Cell Biochem. 1995;58:248-259.
14. Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98:10869-10874.
15. Chelouche-Lev D, Kluger HM, Berger AJ, et al. AlphaB-crystallin as a marker of lymph node involvement in breast carcinoma. Cancer. 2004;100:2543-2548.
16. Pinder SE, Balsitis M, Ellis IO, et al. The expression of alpha B-crystallin in epithelial tumours: a useful tumour marker? J Pathol. 1994;174:209-215.
17. Takashi M, Katsuno S, Sakata T, et al. Different concentrations of two small stress proteins, alphaB crystallin and HSP27 in human urological tumor tissues. Urol Res. 1998;26:395-399.
18. Chin D, Boyle GM, Williams RM, et al. Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer. Laryngoscope. 2005;115:1239-1242.
19. Ivanov O, Chen F, Wiley EL, et al. AlphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat. 2008;111:411-417.
20. Kamradt MC, Chen F, Cryns VL. The small heat shock protein alpha B-crystallin negatively regulates cytochrome c-and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J Biol Chem. 2001;276:16059-16063.
21. Mao YW, Liu JP, Xiang H, et al. Human alphaA-and alphaB-crystallins bind to Bax and Bcl-X(S) to sequester their translocation during staurosporine- induced apoptosis. Cell Death Differ. 2004;11:512-526.
22. Sreekumar PG, Kannan R, KitamuraM, et al.aB crystallin is apically secreted within exosomes by polarized human retinal pigment epithelium and provides neuroprotection to adjacent cells. PLoS One. 2010;5:e12578.
23. Liu S, Li J, Tao Y, et al. Small heat shock protein alphaB-crystallin binds to p53 to sequester its translocation to mitochondria during hydrogen peroxide-induced apoptosis. Biochem Biophys Res Commun. 2007;354:109-114.
24. Watanabe G, Kato S, Nakata H, et al. alphaB-crystallin: a novel p53-target gene required for p53-dependent apoptosis. Cancer Sci. 2009;100:2368-2375.
25. Li DW, Liu JP, Mao YW, et al. Calcium-activated RAF/MEK/ERK signaling pathway mediates p53-dependent apoptosis and is abrogated by alpha B-crystallin through inhibition of RAS activation. Mol Biol Cell. 2005;16:4437-4453.
26. Wechsler-Reya R, Scott MP. The developmental biology of brain tumors. Annu Rev Neurosci. 2001;24:385-428.
27. Stupp R, Hegi ME, van den Bent MJ, et al. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy, G., and National Cancer Institute of Canada Clinical Trials, G. Oncologist. 2006;11:165-180.
28. Robins HI, Chang S, Butowski N, et al. Therapeutic advances for glioblastoma multiforme: current status and future prospects. Curr Oncol Rep. 2007;9:66-70.
29. Aoyama A, Steiger RH, Frö hli E, et al. Expression of alpha B-crystallin in human brain tumors. Int J Cancer. 1993;55:760-764.
30. Goplen D, Bougnaud S, Rajcevic U, et al. aB-crystallin is elevated in highly infiltrative apoptosis-resistant glioblastoma cells. Am J Pathol. 2010;177:1618-1628.
31. Stegh AH, Kesari S, Mahoney JE, et al. Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Proc Natl Acad Sci USA. 2008;105:10703-10708.
32. Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst. 2000;92:1210-1216.
33. Marks PA, Richon VM, Breslow R, et al. Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol. 2001;13:477-483.
34. Finnin MS, Donigian JR, Cohen A, et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature. 1999;401:188-193.
35. Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98-110.
36. Yin D, Ong JM, Hu J, et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo. Clin Cancer Res. 2007;13:1045-1052.
37. Hermisson M, Strik H, Rieger J, et al. Expression and functional activity of heat shock proteins in human glioblastoma multiforme. Neurology. 2000;54:1357-1365.
38. Odreman F, Vindigni M, Gonzales ML, et al. Proteomic studies on lowand high-grade human brain astrocytomas. J Proteome Res. 2005;4:698-708.
39. Liu B, Bhat M, Nagaraj RH. AlphaB-crystallin inhibits glucose-induced apoptosis in vascular endothelial cells. Biochem Biophys Res Commun. 2004;321:254-258.
40. Clark JI, Muchowski PJ. Small heatshock proteins and their potential role in human disease. Curr Opin Struct Biol. 2000;10:52-59.
41. Golenhofen N, Htun P, Ness W, et al. Binding of the stress protein alpha B-crystallin to cardiac myofibrils correlates with the degree of myocardial damage during ischemia/reperfusion in vivo. J Mol Cell Cardiol. 1999;31:569-580.
42. Bruey J, Ducasse MC, Bonniaud P, et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol. 2000;2:645-652.
43. Garrido C, Bruey JM, Fromentin A, et al. HSP27 inhibits cytochrome cdependent activation of procaspase-9. FASEB J. 1999;13:2061-2070.
44. Mehlen P, Preville X, Chareyron P, et al. Constitutive expression of human hsp27, Drosophila hsp27, or human aBcrystallin confers resistance to TNF-and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J Immunol. 1995;154:363-374.
45. Mao YW, Xiang H, Wang W, et al. Human bcl-2 gene attenuates the ability of rabbit lens epithelial cells against H2O2-induced apoptosis through down-regulation of the alpha aB-crystallin gene. J Biol Chem. 2001;278:43435-43445.
46. Scott FL, Denault JB, Riedl SJ, et al. XIAP inhibits caspase-3 and-7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J. 2005;24:645-655.
47. Vaux DL, Silke J. IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol. 2005;6:287-297.
48. Deveraux QL, Takahashi R, Salvesen GS, et al. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 1997;388:300-304.
49. Chawla-Sarkar M, Bae SI, Reu FJ, et al. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ. 2004;11:915-923.
50. McManus DC, Lefebvre CA, Cherton-Horvat G, et al. Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics. Oncogene. 2004;23:8105-8117.
51. Dasari VR, Velpula KK, Kaur K, et al. Cold blood stem cell-mediated induction of apoptosis in glioma downregulates X-liked inhibitor of apoptosis protein (XIAP). PLoS One. 2010;5:11813.
52. Engesæter BO, Sathermugathevan M, Hellenes T, et al. Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells. Cancer Biol Ther. 2011;12:47-58.
53. Di Cresce C, Figueredo R, Ferguson PJ, et al. Combining small interfering RNAs targeting thymidylate synthase and thymidine kinase 1 or 2 sensitizes human tumor cells to 5-fluorodeoxyuridine and pemetrexed. J Pharmacol Exp Ther. 2011;338:952-963.
54. Benoit DS, Henry SM, Shubin AD, et al. pH-responsive polymeric sirna carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of polo-like kinase 1. Mol Pharm. 2010;7:442-455.